Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19-Reference-Cited by-同舟云学术

Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19

Published:2021-04 Issue:4 Volume:2 Page:e138
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Rodionov Roman N,Biener Anne,Spieth Peter,Achleitner Martin,Hölig Kristina,Aringer Martin,Mingrone Geltrude,Corman Victor M,Drosten Christian,Bornstein Stefan R,Tonn Torsten,Kolditz Martin

Publisher

Elsevier BV

Reference5 articles.

1. A randomized trial of convalescent plasma in COVID-19 severe pneumonia;Simonovich;N Engl J Med,2020

2. Early high-titer plasma therapy to prevent severe COVID-19 in older adults;Libster;N Engl J Med,2021

3. Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19;Hueso;Blood,2020

4. Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma;Tonn;Lancet Microbe,2020

5. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer;Aydillo;N Engl J Med,2020

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19;Seminars in Hematology;2024-08

2. THE POTENTIAL OF HUMAN PLASMA AND HUMAN BLOOD PRODUCTS FOR IMMUNE PROTECTION;PROBLEMS of Infectious and Parasitic Diseases;2024-05-07

3. Medical care for SARS-CoV-2;Stem Cells;2024

4. Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients;Transplantation Reviews;2023-12

5. Active and Passive Immunization Approaches in Transplant Recipients;Current Transplantation Reports;2023-08-22